tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Matthew Stanton, 11 are a HOLD (61.11%), 7 are a BUY (38.89%).
Analyst Matthew Stanton, currently employed at JEFFERIES, carries an average stock price target met ratio of 71.67% that have a potential upside of 15.87% achieved within 29 days.
Matthew Stanton’s has documented 35 price targets and ratings displayed on 4 stocks. The coverage is on Industrials, Healthcare sectors.
Most recent stock forecast was given on BLFS, BioLife Solutions at 23-Jul-2026.
Analyst best performing recommendations are on CYRX (CRYOPORT).
The best stock recommendation documented was for CYRX (CRYOPORT) at 8/6/2025. The price target of $8 was fulfilled within 2 days with a profit of $0.75 (8.57%) receiving and performance score of 42.86.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 11-May-2021
$37
$-1.75 (-4.52%)
$37
22 days ago
(14-Sep-2026)
7/31 (22.58%)
$4.96 (15.48%)
100
Buy Since 05-Feb-2026
$35
$-3.75 (-9.68%)
$35
2 months ago
(06-Aug-2026)
12/15 (80%)
$4.26 (13.86%)
84
Buy Since 04-Feb-2026
$40
$14.5 (56.86%)
$38
8 months 2 days ago
(04-Feb-2026)
1/3 (33.33%)
$11.51 (40.40%)
26
Hold Since 27-Feb-2025
$39
$13.5 (52.94%)
$35
8 months 28 days ago
(08-Jan-2026)
3/4 (75%)
$1.5 (4.00%)
36
Buy Since 25-Nov-2025
$45
$19.5 (76.47%)
$35
10 months 11 days ago
(25-Nov-2025)
1/2 (50%)
$6.9 (18.11%)
110
Which stock is Matthew Stanton most bullish on?
What Year was the first public recommendation made by Matthew Stanton?
